CompletedPHASE1, PHASE2NCT00558675

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mirror Biologics, Inc.
Principal Investigator
Dr. Michael Har-Noy
Immunovative Therapies
Intervention
AlloStim(biological)
Enrollment
6 enrolled
Eligibility
18 years · All sexes
Timeline
20102013

Study locations (1)

Collaborators

Hadassah Medical Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00558675 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials